(Q44647501)

5 December 2017

title

The direct healthcare insurer and out-of-pocket expenditures of psoriasis: evidence from a United States national survey (English)

1 reference

5 December 2017

4

1 reference

5 December 2017

3

John A Rizzo

1 reference

5 December 2017

Candace Gunnarsson

1

1 reference

5 December 2017

Jie Chen

series ordinal

2

1 reference

5 December 2017

Ahmad Naim

series ordinal

5

1 reference

5 December 2017

Jennifer H Lofland

series ordinal

6

1 reference

5 December 2017

publication date

31 July 2011

1 reference

Journal of Dermatological Treatment

5 December 2017

published in

1 reference

5 December 2017

volume

23

1 reference

5 December 2017

issue

4

1 reference

5 December 2017

page(s)

240-254

1 reference

The prevalence of psoriasis in African Americans: results from a population-based study.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Psoriasis causes as much disability as other major medical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

The impact of psoriasis on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

The direct cost of care for psoriasis and psoriatic arthritis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Do utilization management controls for phototherapy increase the prescription of biologics?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Recent trends in systemic psoriasis treatment costs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Implications of controlling for comorbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Much ado about two: reconsidering retransformation and the two-part model in health econometrics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Trends in incidence of adult-onset psoriasis over three decades: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Employer-sponsored health insurance in the United States--origins and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

Sensitivity of household reported medical conditions in the medical expenditure panel survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2010.550911

10.3109/09546634.2010.550911

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference